These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9380591)

  • 1. Management of patients receiving transperineal palladium-103 prostate implants.
    Cash JC; Dattoli MJ
    Oncol Nurs Forum; 1997 Sep; 24(8):1361-7. PubMed ID: 9380591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erectile function outcome reporting after clinically localized prostate cancer treatment.
    Burnett AL; Aus G; Canby-Hagino ED; Cookson MS; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus S; Liebert M; Moul JW; Tangen C; Thrasher JB; Thompson I;
    J Urol; 2007 Aug; 178(2):597-601. PubMed ID: 17570435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
    Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
    Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nursing assessment of sexual function following permanent prostate brachytherapy for patients with early-stage prostate cancer.
    Stipetich RL; Abel LJ; Blatt HJ; Galbreath RW; Lief JH; Butler WM; Merrick GS
    Clin J Oncol Nurs; 2002; 6(5):271-4. PubMed ID: 12240487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing considerations in brachytherapy-related erectile dysfunction.
    Stipetich R; Abel LJ; Anderson RL; Butler WM; Wallner KE; Merrick GS
    Urol Nurs; 2005 Aug; 25(4):249-54; quiz 259. PubMed ID: 16225341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy.
    Potters L; Cha C; Oshinsky G; Venkatraman E; Zelefsky M; Leibel S
    Cancer J Sci Am; 1999; 5(5):301-6. PubMed ID: 10526671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
    Niehaus A; Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Adamovich E
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):136-43. PubMed ID: 16198062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy.
    Dauer LT; Zelefsky MJ; Horan C; Yamada Y; St Germain J
    Brachytherapy; 2004; 3(1):1-6. PubMed ID: 15110306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005.
    Colberg JW; Decker RH; Khan AM; McKeon A; Wilson LD; Peschel RE
    Cancer J; 2007; 13(4):229-32. PubMed ID: 17762756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate brachytherapy: a descriptive analysis from CaPSURE.
    Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
    Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.
    Shemtov OM; Radomski SB; Crook J
    Can J Urol; 2004 Dec; 11(6):2450-5. PubMed ID: 15636671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epididymitis after prostate brachytherapy.
    Hoffelt SC; Wallner K; Merrick G
    Urology; 2004 Feb; 63(2):293-6. PubMed ID: 14972474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect on erectile function of 103palladium implantation for localized prostate cancer.
    Ponholzer A; Oismüller R; Somay C; Büchler F; Maier U; Hawliczek R; Rauchenwald M; Madersbacher S
    BJU Int; 2005 Apr; 95(6):847-50. PubMed ID: 15794796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant androgen deprivation prior to transperineal prostate brachytherapy: smaller volumes, less morbidity.
    Blank KR; Whittington R; Arjomandy B; Wein AJ; Broderick G; Staley J; Malkowicz SB
    Cancer J Sci Am; 1999; 5(6):370-3. PubMed ID: 10606479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 103Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: a 12-year experience from a single group practice.
    Sharkey J; Cantor A; Solc Z; Huff W; Chovnick SD; Behar RJ; Perez R; Otheguy J; Rabinowitz R
    Brachytherapy; 2005; 4(1):34-44. PubMed ID: 15737905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
    Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
    Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.